242 related articles for article (PubMed ID: 18673231)
21. The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis.
Collet JP; Moen JL; Veklich YI; Gorkun OV; Lord ST; Montalescot G; Weisel JW
Blood; 2005 Dec; 106(12):3824-30. PubMed ID: 16091450
[TBL] [Abstract][Full Text] [Related]
22. Dynamic changes of fibrin architecture during fibrin formation and intrinsic fibrinolysis of fibrin-rich clots.
Collet JP; Lesty C; Montalescot G; Weisel JW
J Biol Chem; 2003 Jun; 278(24):21331-5. PubMed ID: 12642590
[TBL] [Abstract][Full Text] [Related]
23. Peroxynitrite may affect fibrinolysis via the reduction of platelet-related fibrinolysis resistance and alteration of clot structure.
Misztal T; Rusak T; Brańska-Januszewska J; Ostrowska H; Tomasiak M
Free Radic Biol Med; 2015 Dec; 89():533-47. PubMed ID: 26454084
[TBL] [Abstract][Full Text] [Related]
24. Direct microscopic monitoring of initial and dynamic clot lysis using plasmin or rt-PA in an in vitro flow system.
Bizjak N; Bajd F; Vidmar J; Blinc A; Perme MP; Marder VJ; Novokhatny V; Serša I
Thromb Res; 2014 May; 133(5):908-13. PubMed ID: 24613694
[TBL] [Abstract][Full Text] [Related]
25. DNA, histones and neutrophil extracellular traps exert anti-fibrinolytic effects in a plasma environment.
Varjú I; Longstaff C; Szabó L; Farkas ÁZ; Varga-Szabó VJ; Tanka-Salamon A; Machovich R; Kolev K
Thromb Haemost; 2015 Jun; 113(6):1289-98. PubMed ID: 25789443
[TBL] [Abstract][Full Text] [Related]
26. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
[TBL] [Abstract][Full Text] [Related]
27. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
[TBL] [Abstract][Full Text] [Related]
28. Modulation of fibrinolysis by the combined action of phospholipids and immunoglobulins.
Gombás J; Tanka-Salamon A; Skopál J; Nagy Z; Machovich R; Kolev K
Blood Coagul Fibrinolysis; 2008 Jan; 19(1):82-8. PubMed ID: 18180621
[TBL] [Abstract][Full Text] [Related]
29. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M
Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740
[TBL] [Abstract][Full Text] [Related]
30. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy.
Collet JP; Park D; Lesty C; Soria J; Soria C; Montalescot G; Weisel JW
Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1354-61. PubMed ID: 10807754
[TBL] [Abstract][Full Text] [Related]
31. Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro.
Sakharov DV; Barrertt-Bergshoeff M; Hekkenberg RT; Rijken DC
Thromb Haemost; 1999 Apr; 81(4):605-12. PubMed ID: 10235448
[TBL] [Abstract][Full Text] [Related]
32. Modelling fibrinolysis: 1D continuum models.
Bannish BE; Keener JP; Woodbury M; Weisel JW; Fogelson AL
Math Med Biol; 2014 Mar; 31(1):45-64. PubMed ID: 23220467
[TBL] [Abstract][Full Text] [Related]
33. A comparative study of the efficacy and specificity of tissue plasminogen activator and pro-urokinase: demonstration of synergism and of different thresholds of non-selectivity.
Gurewich V; Pannell R
Thromb Res; 1986 Oct; 44(2):217-28. PubMed ID: 3097872
[TBL] [Abstract][Full Text] [Related]
34. Microfluidic Modeling of Thrombolysis.
Loyau S; Ho-Tin-Noé B; Bourrienne MC; Boulaftali Y; Jandrot-Perrus M
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2626-2637. PubMed ID: 30354249
[TBL] [Abstract][Full Text] [Related]
35. Computer simulation of systemic circulation and clot lysis dynamics during thrombolytic therapy that accounts for inner clot transport and reaction.
Anand S; Diamond SL
Circulation; 1996 Aug; 94(4):763-74. PubMed ID: 8772700
[TBL] [Abstract][Full Text] [Related]
36. Endogenous fibrinolysis facilitates clot retraction in vivo.
Samson AL; Alwis I; Maclean JAA; Priyananda P; Hawkett B; Schoenwaelder SM; Jackson SP
Blood; 2017 Dec; 130(23):2453-2462. PubMed ID: 29074499
[TBL] [Abstract][Full Text] [Related]
37. Fibrin clots obtained from plasma containing heparin show a higher sensitivity to t-PA-induced lysis.
Nenci GG; Parise P; Morini M; Rossini A; Agnelli G
Blood Coagul Fibrinolysis; 1992 Jun; 3(3):279-85. PubMed ID: 1643205
[TBL] [Abstract][Full Text] [Related]
38. Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbetaGly15Cys (Hamamatsu II).
Kamijyo Y; Hirota-Kawadobora M; Yamauchi K; Terasawa F; Honda T; Ikeya M; Okumura N
Blood Coagul Fibrinolysis; 2009 Dec; 20(8):726-32. PubMed ID: 19809304
[TBL] [Abstract][Full Text] [Related]
39. A precise and rapid microtitre plate clot lysis assay: methodology, kinetic modeling and measurement of catalytic constants for plasminogen activation during fibrinolysis.
Jones AJ; Meunier AM
Thromb Haemost; 1990 Nov; 64(3):455-63. PubMed ID: 2128976
[TBL] [Abstract][Full Text] [Related]
40. Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.
Sakata Y; Aoki N
J Clin Invest; 1982 Mar; 69(3):536-42. PubMed ID: 7199538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
